Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,580
Award facts
- Contract value 100% obligated
- $23,579.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,579.88 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Calquence 100 mg tablets (60-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 4, 2026, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and other federal healthcare systems. The company competes on a full and open basis for government contracts and supplies a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Calquence, an oncology medication, exemplifies the company's role in supporting military and federal healthcare operations with critical pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F4E9J?
SPE2DR26F4E9J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F4E9J worth?
The government has obligated $23,580 on SPE2DR26F4E9J.
Is contract SPE2DR26F4E9J an order under another contract?
Yes. SPE2DR26F4E9J is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E9J competed?
The extent of competition for SPE2DR26F4E9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award